Start

Therapy with Recombinant Factor VIIa in a Patient with a Factor VIII or IX Inhibitor

Description:

Recombinant activated Factor VII (rFVIIa) can be used to control hemorrhage in a patient with Factor VIII or IX inhibitors. These inhibitors usually occur in patients with hemophilia, but occasionally may be encountered as an autoantibody.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone